|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
FY2020
12 months to Dec 31, 2020
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Stock-based compensation expense | |||||
| Write-off of debt issuance costs | |||||
| Restructuring, severance and related costs | |||||
| Paid-in-kind interest expense | |||||
| Bad debt expense | |||||
| Gain on termination of operating lease | |||||
| Write-off of other asset | |||||
| Depreciation expense | |||||
| Amortization expense | |||||
| Gain on forgiveness of PPP loan | |||||
| Change in fair value of warrants | |||||
| Change in fair value of contingent consideration | |||||
| 401(k) employer match in common shares | |||||
| Common stock issued for consulting services | |||||
| Debt issuance costs expense | |||||
| Public Offering Warrants and Private Placement Warrants | |||||
| Demand Warrants | |||||
| Total debt issuance costs expense | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Unbilled receivables | |||||
| Prepaid expenses and other assets | |||||
| Accounts payable | |||||
| Deferred revenue | |||||
| Lease liabilities | |||||
| Other accrued liabilities | |||||
| Net cash used in operating activities | |||||
| Cash flows from investing activities | |||||
| Purchases of property and equipment | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities | |||||
| Proceeds from Demand Notes | |||||
| Proceeds from Keep Well Notes | |||||
| Proceeds from Keep Well Agreement held in escrow and funded Private Placement | |||||
| Common stock, Pre-Funded Warrants and Warrants issued in Public Offering | |||||
| Financing transaction costs | |||||
| Proceeds from issuance of common stock | |||||
| Proceeds from warrants exercised | |||||
| Proceed from options exercise | |||||
| Financed insurance premium payments | |||||
| Finance lease obligations | |||||
| Dividends paid | |||||
| Payment of taxes related to net-settled stock awards | |||||
| Net cash provided by financing activities | |||||
| Net change in cash and restricted cash | |||||
| Cash and restricted cash at beginning of period | |||||
| Cash at end of period | |||||
| Supplemental disclosure of cash flow information: | |||||
| Interest paid | |||||
| Income taxes paid | |||||
| Non-cash financing and investing activities: | |||||
| Debt issuance costs | |||||
| Public Offering Warrants and Private Placement Warrants | |||||
| Total debt issuance costs | |||||
| Conversion of Keep Well Notes to Common Stock and Warrants Issued | |||||
| Keep Well Note cancelled and funded Private Placement | |||||
| Common stock issued in connection with Keep Well Agreement | |||||
| Warrants issued | |||||
| 2024 Notes | |||||
| Keep Well Note | |||||
| Warrants issued in connection with Keep Well Notes and 2024 Notes, adjusted for repricing | |||||
| Losses on extinguishments of debt with related party | |||||
| Write-off of debt issuance costs related to conversion of Keep Well Notes | |||||
| Write-off of debt issuance costs related to cancelled Keep Well Notes in Private Placement | |||||
| Financed insurance premiums | |||||
| Finance lease and accrued purchases of property and equipment | |||||
| Common stock issued to settle contingent liability | |||||
Loading...